A novel approach of longitudinal adverse event evaluation in oncology clinical trials: the Toxicity over Time (ToxT) analysis of clinical trials N9741 and 979254 (Alliance)
      QxMD      Google Scholar   
Citation:
Lancet Oncol vol 17 (5) 663-670
Year:
2016
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
Yes
Biospecimen:
No
SDC:
No
Book Volume:
5
Parents:
None
Children:
None
Program:
CCP
Primary Committee:
Health Outcomes
Sec. Committees:
   
Pharmas:
 
Grants:
P30 CA015083, U10 CA180867, UG1 CA189823  
Corr. Author:
 
Authors:
             
Networks:
LAPS-MN026   
Study
Multiple Studies, or Legacy Studies in Alliance Study:
NCCTG-N9741, NCCTG-97-92-54
Phases:
3
Keywords:
toxicity, clinical trials, adverse events